SlideShare a Scribd company logo
Endometriosis with low AMH.
How to deal with it
PROF. ROKEYA BEGUM
Advisor
Dept. of Obs and Gynecology USTC.
Director
Surgiscope fertility centre
Chittagong.
Endometriosis is a….
Disease of theories and debates
Endometriosis….
i) Defined as the presence of endometrial tissue (gland/stroma) outside the
uterus.
ii) Prevalence is 7-15% of reproductive age women .
iii) 70 million of women are affected with endometriosis 30% of these women
are infertile.
iv) Estrogen dependent
- Rare before menarche and after menopause.
- Not in male
v) Progressive disease
vi) Cure by pregnancy
Sites of Endometriosis…
i) Peritoneum
ii) Ovaries
iii) Rectovaginal septum
iv) Urinary bladder
v) GI Tract
Ovarian function…
i) Hormone production
ii) Maintenance of follicular development
iii) Reservoir of dormant oocyte.
Pathogenesis of ovarian endometriosis is still a matter of debate.
- Superficial ovarian endometriosis.
- Accumulation and activation of pelvic macrophage.
Local inflammatory response, fibrosis of cortical tissue damage of dormant primordial follicle
Progression of formation of endometriotic lesion in superficial ovarian cortex
Provoke invagination of ovarian superficial endometriosis facilitates cyst formation.
The cyst wall of endometriosis may show various degree of haemosiderin laden macrophages.
Cyst wall show dense fibrosis adjacent to normal ovarian time.
The multipotent stem cells which can form endometriotic
lesion and further progression of stem cell derived lesion via
tissue remodelling may be modulated by ovarian steriod
hormone and local inflammation.
Accumulation and trafficking of these stem cells can be
stimulated by oestradiol and immune cells.
Local immune cells such as in variant natural killer T (NKT)
cells may be involved in pathogenesis of endometriosis.
Ovarian steroid hormone production
The direct effects of endometriosis on ovarian steroid hormone production
are unclear.
Altered follicular development can result in decreased hormone production
lower level of oestrogen and progesterone have been noted in serum and
urine .
Impairment of ovulatory process causes LUFS. The causal relationship
between endometriosis and LUFS are unclear and controversial.
Oocyte quality…
Oocyte maturity can be affected by inflammatory intrafollicular
environment. The presence of intrafollicular oxidative stress in
patients with endometriosis is an event that is directly linked to
reduced oocyte quality and infertility.
Oxidative stress brought by hemorrhagic chocolate fluids in
endometriosis may spread to surrounding normal ovarian tissue.
Assessment of quality of follicle in clinical setting is not straight
forward.
Quantity…
Ovarian reserve is a term concerning the quality and quantity of
ovarian follicles remains at certain time points.
Ovarian reserve may refer to the quantity of remaining primordial
follicles are formed in the course of ovarian development in foetal life
than they maintain dormancy until they are activated in later
reproductive life.
Presence of ovarian endometriosis on ovarian
reserve-
1.Adjacent ovarian tissue is morphologically altered but not functionally.
2.Compression by cyst hamper circulation and causes follicular loss.
3. Inflammatory reaction causes follicular damage.
4. Impaired vascularization.
5.High concentration of iron in cyst mediates the production of reactive
oxygen species. Reactive oxygen species (ROS) along with transforming
growth factor  is potent inducer of tissue fibrosis which causes follicular
loss. Reactive oxygen species (ROS) is responsible for progressive ovarian
tissue damage.
Ovarian reserve tests
Assessment of ovarian reserve in endometriosis has to
be done by-
• Serum Antimullerian hormone (AMH)
• Serum Follicle stimulating hormone (FSH)
• Antral follicle count (AFC)
FSH and AFC have limitation-
• FSH – higher intercycle variation
• AFC – Not accurate with endometrioma.
Indeed in two large Cohot studies shown women
with history of endometriosis related infertility
are reported to experience menopause earlier
than women without endometriosis.
Endometriosis patients suffers from…
1. Pain
2. Infertility
3. Menstrual disturbances
4. Lump in lower abdomen
5. Quality of life
6. Negative influence on sexual function
7. Inter personal relationship.
Endometriosis is associated with infertility..
Fertility reduction is subjective choice and
women could be informed but absolutely must
not be terrorized leading to unnecessary stress
and intervention.
Treatment of endometriosis is individualized
1. Medical
2. Surgical
3. ART alone or combination
* Medical treatment :
- long term suppression
- Reduces pain
- Reduced growth of lesion
- Protect ovarian function
1. GnRh agonist
2. Dienogest
• Medical treatment suppresses general and
peripheral oestrogen production result in better
treatment outcome in ART cycle.
• Reduction of endometriosis activity may
restore endometrial receptivity as well as
maintenance of ovarian reserve.
1. GnRh agonist -
a. Reduce cyst size
b. Reduction of hyper vascularization and inflammation.
c. Reduction of cyst wall thickness.
d. Absence of corpus luteum or follicle.
e. Facilitation of surgery
f. Reduction of adhesion
Recommendation
GnRh
1. Prior to IVF
2.Prior to surgery
2. Dienogest -
Acts on multiple receptors
a) Oestrogen
b) Androgen
c) Gluco corticoid
d) Mineralo corticoid
Dienogest has little impact on the metabolic parameter and
having a significant impact on endometriotic lesion locally.
Dienogest has -
a. anti inflammatory
b. Modulation of proinflammatory cytokine and chemokine
production-which mediates via progesterone receptor.
It is questionable whether dienogest can improve the clinical
outcome if use before IVF or surgery.
Surgery indicated in
i) large endometrioma > 4cm
ii) Extensive pelvic endometriosis
iii) Prior IVF
iv) Failure to hormone therapy
Surgical treatment-
Conservative surgery
1. Excision
2. Drainage
3. Ablation
Aim of surgery
Reconstruction of normal pelvic anatomy to achieve an
excellent tubo-ovarian relationship and removed all visible disease .
Laparoscopy is preferred over laparotomy.
Ovarian tissue was present in cyst wall
- 65% laparoscopy stripping
- 80% laparotomy.
All ovarian cyst are not created equal
Ovarian tissue removed
Well defined Capsule
Dermoid 6%
Serious cyst adenoma
Mucinous cyst adenoma
Endometrioma
54-69%
(Margin of the ovarian tissue)
The structural difference among different ovarian cysts yield
different amounts of adjacent ovarian tissue when they are
removed.
Endometriosis is a false cyst and its cyst wall is
the same as the ovarian cortex.
Therefore unsafe removal of pseudo cyst may
damage the ovary and interfere with future
fertility.
Laparoscopy is Gold standard.
Ongoing pregnancy rate increased in infertile
women with endometriosis after laparoscopy.
Chance of pregnancy increased from 38-71%
cases.
Benefits of surgery…
a. Decreased inflammations in pelvis.
b. Decreased toxicity to gametes.
c. Enhance uterine receptivity.
High recurrence rate versus potential harmful effects on
ovarian reserve make it difficult to select the most
effective treatment modality for endometriosis.
• Incomplete excision – recurrence high
• Excessive excision – reduced reserve
Recurrence of endometriosis:
The reported recurrence rate was high
=> 21.5% at 2 yrs
=> 40-50% at 5 yrs
Repeat surgery - 25%
Reduction of ovarian reserve due to-
a. Removal of healthy tissue during stripping.
b.Vascular injury to electrosurgical coagulation.
c. Inflammatory reaction.
Surgical technique for cystectomy-
1. Mobilisation of ovaries
2. During mobilisation cyst usually drain
on itself from the weakest point.
3. Cyst decompression by suction drainage.
4. Pitressin/vesopressin injection.
5. Cyst wall removed from normal ovarian tissue by traction and
counter traction.
6. Achieve complete haemostasis by suture not by bipolar current.
Three step techniques for ovarian endometrioma
1. Laparoscopic drainage
2. GnRh for 3 months
3. Laparoscopic Co2 laser vaporization.
The factors which determine the amount of loss of
follicles during surgery is dependent on many factors:
1. Use of electro cautery
2. Amount of inflammation
3. Number of pre existing follicle
4. Endometrioma is bilateral
5. Previous surgery
6. Expertise of surgery
Several cross section shows endometrioma had
lower ovarian reserve without surgery then
healthy women.
This decline is progressive in the absence
of any intervention and greater in
magnitude.
Ovarian reserve in endometriosis depends on-
a. Bilateral / unilateral disease.
b. Size of cyst
c. Severe adhesion
d. Fibrosis
e. Disease duration
f. Women’s age
g.Recurrence
• 30% AMH reduction – unilateral
• 44% AMH reduction – bilateral
Surgery ART
Age Young Old
Associated factor
- Male
- Tube
No Yes
Infertility duration Short Long
Ovarian reserve Satisfactory Reduced
Pelvic pain Severe Mild
Ovarian Endometrioma
bilateral
No Yes
Previous surgery No Yes
Adenomyomis No Yes
Anti mullerian hormone level in women with endometriosis.
A case-control study.
Object – To compare the Antimullarian hormone (AMH) level in
women with or without endometriosis.
Design – A case control study
Getting – Women’s general hospital, Lint, Austria.
Result – Mean AMH level was significantly lower in the study group
than in the control group (2.75 + 2.0mg/ml vs 3.46 + 2.30mg/ml P0.001)
OMAR SHEBL 2009.
Effect of ovarian endometrioma on the number of oocyte retrieved
for in vitro fertilization.
Objective – To evaluate the effects of ovarian endometrioma on the number of oocytes retrieved
for IVF.
Setting – University based tertiary medical center.
Patients – 81 women with unilateral endometrioma who under want first IVF cycle.
Main outcome measures –
The number of antral follicles and the retrieved oocyte in the ovary that contained endometrioma
were compared with those from contralaterd ovary results –Antral follicle count and number of
retrieved oocytes in these women were similar to those with no endometrionma.
Conclusion - The presence of ovarian endometrioma in a controlled ovarian hyper stimulation
cycle for IVF treatment is not associated with reduced number of oocytes retrieved from affected
ovary.
Benny Almog 2010
The impact of electrocoagulation on ovarian
reserve after laparoscopic excision of ovarian cyst .
Design-Prospective clinical study on 191 patients.
Objective- Bipolar, Ultrasonic scalpel and Suture.
Result- Significant reduction in ovarian reserve in bipolar.
Chang Zhong Li- 2009
Endometriosis patient should be assessed
individually and follow seven guidelines in order
to preserve fertility.
1. Choosing the best surgical techniques.
Still not known which one is most effective.
Surgery can lead to reduction in ovarian reserve
i) Excessive stripping
ii) Disease itself
iii) Cauterization to stop bleeding
iv) Surgery induce inflammation
v) Cystectomy
vi) Bilateral
vii) Large endometriona
2. Avoid unnecessary surgery
- No surgery if size less than 4cm
- No pain.
3. Measure ovarian reserve before surgery.
a) Discussion of risks and benefits of surgery.
b) Allowing the surgery to optimize and individual treatment
modalities.
c) Aggressive nature of surgery should be avoided.
d) Fertility preservation should be offered.
4. Emergency IVF before surgery
1. Older patient > 38yrs
2. Prolong infertility
3. Low AMH
5. Use of GnRh analogues
i) Hypoestrogenic state
ii) Increase natural killer cell activity and diminished
embryotoxic effects of peritoneal fluid
iii) Ovarian parenchyma damage during the surgery seems to
be related to cyst diameter.
GnRh analogue is useful for both before surgery and IVF.
6. Fertility preservation/Cryopreservation
i) Oocyte freezing
ii) Embryo freezing
iii) Ovarian cortical tissue freezing
Oocyte freezing
Survival rate 85%
Fertilization rate 75%
Pregnancy rate > 40%
Disadvantage
i) Zona hardening
ii) Chromosomal aneuploidy
iii) Karyotype abnormality
iv) Organ malfunction
v) Damage cytoskeleton
Ovarian cortical tissue cryopreservation
- Re implantation of cortical ovarian tissue into the pelvic cavity or
heterotopic site.
- When patient become disease free, the implanted tissue can be used
in IVF and ET procedure.
This method is associated with 25% follicle survival and is most successful
when patient is young.
Ovarian tissue cryopreservation
is still experimental although
pregnancies have been reported.
7.Role of lifestyle changes in infertile patient with endometriosis-
i) Avoid late childhood obesity
ii) Avoid high trans fat
iii) Avoid caffeine
iv) Avoid alcohol
ART is a hope of ray for
Infertile patient with low AMH.
Conclusion
Endometriosis

More Related Content

What's hot

recurrent pregnancy loss
recurrent pregnancy lossrecurrent pregnancy loss
recurrent pregnancy loss
Kamel Ibrahim
 
Placenta Accreta Spectrum Disorders Challenges and management
Placenta Accreta Spectrum Disorders Challenges and managementPlacenta Accreta Spectrum Disorders Challenges and management
Placenta Accreta Spectrum Disorders Challenges and management
Ahmed Elbohoty
 
Recurrent Implantation Failure
Recurrent Implantation FailureRecurrent Implantation Failure
Recurrent Implantation Failure
Shivani Sachdev
 
Icsi preparation
Icsi preparationIcsi preparation
Icsi preparation
nermine amin
 
Fertility preservation Egg freezing
Fertility preservation  Egg freezing   Fertility preservation  Egg freezing
Fertility preservation Egg freezing
NikosFVlahosMDPhD
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
faheta
 
1. recurrent pregnancy loss
1. recurrent pregnancy loss  1. recurrent pregnancy loss
1. recurrent pregnancy loss
DrRokeyaBegum
 
An update on recurrent pregnancy loss 2015
An update on  recurrent pregnancy loss 2015An update on  recurrent pregnancy loss 2015
An update on recurrent pregnancy loss 2015
Lifecare Centre
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
Niranjan Chavan
 
Recurrent miscarriage guidelines
Recurrent miscarriage guidelinesRecurrent miscarriage guidelines
Recurrent miscarriage guidelines
muhammad al hennawy
 
Systemic lupus erythematosus during pregnancy
Systemic  lupus erythematosus  during  pregnancySystemic  lupus erythematosus  during  pregnancy
Systemic lupus erythematosus during pregnancy
DrRokeyaBegum
 
recurrent pregnancy loss : new concept
recurrent pregnancy loss : new conceptrecurrent pregnancy loss : new concept
recurrent pregnancy loss : new concept
Hesham Al-Inany
 
Management of infertility
Management of infertilityManagement of infertility
Management of infertility
Aboubakr Elnashar
 
Identifying the Signs for Implantation Failure and Miscarriage
Identifying the Signs for Implantation Failure and MiscarriageIdentifying the Signs for Implantation Failure and Miscarriage
Identifying the Signs for Implantation Failure and Miscarriage
NEW LIFE- IVF CLINIC INDIA
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
Aboubakr Elnashar
 
Assisted reproductive technology 1106 ppt
Assisted reproductive technology 1106 pptAssisted reproductive technology 1106 ppt
Assisted reproductive technology 1106 ppt
鋒博 蔡
 
Repeated implantation failure.warda full
Repeated implantation failure.warda fullRepeated implantation failure.warda full
Repeated implantation failure.warda full
Osama Warda
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
Dr.Laxmi Agrawal Shrikhande
 
Perimenopausal Bleeding a Pragmatic Approach
Perimenopausal Bleeding a Pragmatic ApproachPerimenopausal Bleeding a Pragmatic Approach
Perimenopausal Bleeding a Pragmatic Approach
Dr.Laxmi Agrawal Shrikhande
 
Evidence based infertility management
Evidence based infertility managementEvidence based infertility management
Evidence based infertility management
Hesham Al-Inany
 

What's hot (20)

recurrent pregnancy loss
recurrent pregnancy lossrecurrent pregnancy loss
recurrent pregnancy loss
 
Placenta Accreta Spectrum Disorders Challenges and management
Placenta Accreta Spectrum Disorders Challenges and managementPlacenta Accreta Spectrum Disorders Challenges and management
Placenta Accreta Spectrum Disorders Challenges and management
 
Recurrent Implantation Failure
Recurrent Implantation FailureRecurrent Implantation Failure
Recurrent Implantation Failure
 
Icsi preparation
Icsi preparationIcsi preparation
Icsi preparation
 
Fertility preservation Egg freezing
Fertility preservation  Egg freezing   Fertility preservation  Egg freezing
Fertility preservation Egg freezing
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
1. recurrent pregnancy loss
1. recurrent pregnancy loss  1. recurrent pregnancy loss
1. recurrent pregnancy loss
 
An update on recurrent pregnancy loss 2015
An update on  recurrent pregnancy loss 2015An update on  recurrent pregnancy loss 2015
An update on recurrent pregnancy loss 2015
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
 
Recurrent miscarriage guidelines
Recurrent miscarriage guidelinesRecurrent miscarriage guidelines
Recurrent miscarriage guidelines
 
Systemic lupus erythematosus during pregnancy
Systemic  lupus erythematosus  during  pregnancySystemic  lupus erythematosus  during  pregnancy
Systemic lupus erythematosus during pregnancy
 
recurrent pregnancy loss : new concept
recurrent pregnancy loss : new conceptrecurrent pregnancy loss : new concept
recurrent pregnancy loss : new concept
 
Management of infertility
Management of infertilityManagement of infertility
Management of infertility
 
Identifying the Signs for Implantation Failure and Miscarriage
Identifying the Signs for Implantation Failure and MiscarriageIdentifying the Signs for Implantation Failure and Miscarriage
Identifying the Signs for Implantation Failure and Miscarriage
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
 
Assisted reproductive technology 1106 ppt
Assisted reproductive technology 1106 pptAssisted reproductive technology 1106 ppt
Assisted reproductive technology 1106 ppt
 
Repeated implantation failure.warda full
Repeated implantation failure.warda fullRepeated implantation failure.warda full
Repeated implantation failure.warda full
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
 
Perimenopausal Bleeding a Pragmatic Approach
Perimenopausal Bleeding a Pragmatic ApproachPerimenopausal Bleeding a Pragmatic Approach
Perimenopausal Bleeding a Pragmatic Approach
 
Evidence based infertility management
Evidence based infertility managementEvidence based infertility management
Evidence based infertility management
 

Similar to Endometriosis

Presentation (1).pptx
Presentation (1).pptxPresentation (1).pptx
Presentation (1).pptx
chitragupta55
 
Presentation (1).pptx
Presentation (1).pptxPresentation (1).pptx
Presentation (1).pptx
chitragupta55
 
Presentation%20(2).pptx
Presentation%20(2).pptxPresentation%20(2).pptx
Presentation%20(2).pptx
chitragupta55
 
Presentation (1).pptx
Presentation (1).pptxPresentation (1).pptx
Presentation (1).pptx
chitragupta55
 
Future Directions in Endometriosis Management 11.04.2021.pptx
Future Directions in Endometriosis Management 11.04.2021.pptxFuture Directions in Endometriosis Management 11.04.2021.pptx
Future Directions in Endometriosis Management 11.04.2021.pptx
Kawita Bapat
 
Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)
Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)
Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)
SMVDCoN ,J&K
 
Seminar presentation on uterine fibroid
Seminar presentation on uterine fibroidSeminar presentation on uterine fibroid
Seminar presentation on uterine fibroid
meghnaneelamana
 
When more is not better: The 10 ‘Don’ts’ in Endometriosis Management
When more is not better: The 10 ‘Don’ts’ in Endometriosis ManagementWhen more is not better: The 10 ‘Don’ts’ in Endometriosis Management
When more is not better: The 10 ‘Don’ts’ in Endometriosis Management
Ahmed Al Amely
 
Management Of Endometrosis
Management Of EndometrosisManagement Of Endometrosis
Management Of Endometrosis
Dr Odejayi Mary Abosede
 
Managemnt of endometrosis
Managemnt of endometrosisManagemnt of endometrosis
Managemnt of endometrosis
Dr Odejayi Mary Abosede
 
Managemnt of endometrosis
Managemnt of endometrosisManagemnt of endometrosis
Managemnt of endometrosis
Dr Odejayi Mary Abosede
 
Do Women Need A Surgery When Suffering From Endometriosis?
Do Women Need A Surgery When Suffering From Endometriosis?Do Women Need A Surgery When Suffering From Endometriosis?
Do Women Need A Surgery When Suffering From Endometriosis?
FFragrant
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Marwan Alhalabi
 
gyanaecology.endometriosis and adenomyosis.(dr.salama)
gyanaecology.endometriosis and adenomyosis.(dr.salama)gyanaecology.endometriosis and adenomyosis.(dr.salama)
gyanaecology.endometriosis and adenomyosis.(dr.salama)
student
 
endometriosis
endometriosisendometriosis
endometriosis
Karl Daniel, M.D.
 
Myoma and Infertility: What next?
Myoma and Infertility: What next?Myoma and Infertility: What next?
Myoma and Infertility: What next?
Sujoy Dasgupta
 
Leiomyomata uteri
Leiomyomata uteriLeiomyomata uteri
Leiomyomata uteri
Sravanthi Nuthalapati
 
endometriozis (2).pptx
endometriozis (2).pptxendometriozis (2).pptx
endometriozis (2).pptx
TeonaMacharashvili
 
Adenomyosis and Reproduction
Adenomyosis and Reproduction Adenomyosis and Reproduction
Adenomyosis and Reproduction
iCliniq
 
Infertility in Endometriosis management.
Infertility in Endometriosis management.Infertility in Endometriosis management.
Infertility in Endometriosis management.
pharmaworld2019
 

Similar to Endometriosis (20)

Presentation (1).pptx
Presentation (1).pptxPresentation (1).pptx
Presentation (1).pptx
 
Presentation (1).pptx
Presentation (1).pptxPresentation (1).pptx
Presentation (1).pptx
 
Presentation%20(2).pptx
Presentation%20(2).pptxPresentation%20(2).pptx
Presentation%20(2).pptx
 
Presentation (1).pptx
Presentation (1).pptxPresentation (1).pptx
Presentation (1).pptx
 
Future Directions in Endometriosis Management 11.04.2021.pptx
Future Directions in Endometriosis Management 11.04.2021.pptxFuture Directions in Endometriosis Management 11.04.2021.pptx
Future Directions in Endometriosis Management 11.04.2021.pptx
 
Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)
Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)
Ectopic pregnancy,Fibroid,Gestational Trophoblastic Disease (GTD)
 
Seminar presentation on uterine fibroid
Seminar presentation on uterine fibroidSeminar presentation on uterine fibroid
Seminar presentation on uterine fibroid
 
When more is not better: The 10 ‘Don’ts’ in Endometriosis Management
When more is not better: The 10 ‘Don’ts’ in Endometriosis ManagementWhen more is not better: The 10 ‘Don’ts’ in Endometriosis Management
When more is not better: The 10 ‘Don’ts’ in Endometriosis Management
 
Management Of Endometrosis
Management Of EndometrosisManagement Of Endometrosis
Management Of Endometrosis
 
Managemnt of endometrosis
Managemnt of endometrosisManagemnt of endometrosis
Managemnt of endometrosis
 
Managemnt of endometrosis
Managemnt of endometrosisManagemnt of endometrosis
Managemnt of endometrosis
 
Do Women Need A Surgery When Suffering From Endometriosis?
Do Women Need A Surgery When Suffering From Endometriosis?Do Women Need A Surgery When Suffering From Endometriosis?
Do Women Need A Surgery When Suffering From Endometriosis?
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
 
gyanaecology.endometriosis and adenomyosis.(dr.salama)
gyanaecology.endometriosis and adenomyosis.(dr.salama)gyanaecology.endometriosis and adenomyosis.(dr.salama)
gyanaecology.endometriosis and adenomyosis.(dr.salama)
 
endometriosis
endometriosisendometriosis
endometriosis
 
Myoma and Infertility: What next?
Myoma and Infertility: What next?Myoma and Infertility: What next?
Myoma and Infertility: What next?
 
Leiomyomata uteri
Leiomyomata uteriLeiomyomata uteri
Leiomyomata uteri
 
endometriozis (2).pptx
endometriozis (2).pptxendometriozis (2).pptx
endometriozis (2).pptx
 
Adenomyosis and Reproduction
Adenomyosis and Reproduction Adenomyosis and Reproduction
Adenomyosis and Reproduction
 
Infertility in Endometriosis management.
Infertility in Endometriosis management.Infertility in Endometriosis management.
Infertility in Endometriosis management.
 

More from DrRokeyaBegum

Obstetric Haemorrhage [Autosaved].pptx
Obstetric Haemorrhage [Autosaved].pptxObstetric Haemorrhage [Autosaved].pptx
Obstetric Haemorrhage [Autosaved].pptx
DrRokeyaBegum
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
DrRokeyaBegum
 
Stimulation protocol in ART: should we tailor it on AMH level?
Stimulation protocol in ART: should we tailor it on AMH level?Stimulation protocol in ART: should we tailor it on AMH level?
Stimulation protocol in ART: should we tailor it on AMH level?
DrRokeyaBegum
 
caesarean myomectomy ppt.pptx
caesarean myomectomy ppt.pptxcaesarean myomectomy ppt.pptx
caesarean myomectomy ppt.pptx
DrRokeyaBegum
 
vvf ppt.ppt
vvf ppt.pptvvf ppt.ppt
vvf ppt.ppt
DrRokeyaBegum
 
Optimization of outcomes of .pptx
Optimization of outcomes of  .pptxOptimization of outcomes of  .pptx
Optimization of outcomes of .pptx
DrRokeyaBegum
 
myomectomy.pptx
myomectomy.pptxmyomectomy.pptx
myomectomy.pptx
DrRokeyaBegum
 
Diagnosis of PCOS MCMCTACONSESSION4.pptx
Diagnosis of PCOS MCMCTACONSESSION4.pptxDiagnosis of PCOS MCMCTACONSESSION4.pptx
Diagnosis of PCOS MCMCTACONSESSION4.pptx
DrRokeyaBegum
 
COMPLICATIONS OF ASSISTED REPROUCTIVE TECHIQUES
COMPLICATIONS  OF ASSISTED REPROUCTIVE TECHIQUESCOMPLICATIONS  OF ASSISTED REPROUCTIVE TECHIQUES
COMPLICATIONS OF ASSISTED REPROUCTIVE TECHIQUES
DrRokeyaBegum
 
PCOS.pptx
PCOS.pptxPCOS.pptx
PCOS.pptx
DrRokeyaBegum
 
Trends of ovulation induction in PCOS
Trends of ovulation induction in PCOSTrends of ovulation induction in PCOS
Trends of ovulation induction in PCOS
DrRokeyaBegum
 
Massive Postpartum haemorrhage
Massive Postpartum haemorrhageMassive Postpartum haemorrhage
Massive Postpartum haemorrhage
DrRokeyaBegum
 
Pruritus in pregnancy
Pruritus in pregnancyPruritus in pregnancy
Pruritus in pregnancy
DrRokeyaBegum
 

More from DrRokeyaBegum (13)

Obstetric Haemorrhage [Autosaved].pptx
Obstetric Haemorrhage [Autosaved].pptxObstetric Haemorrhage [Autosaved].pptx
Obstetric Haemorrhage [Autosaved].pptx
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
 
Stimulation protocol in ART: should we tailor it on AMH level?
Stimulation protocol in ART: should we tailor it on AMH level?Stimulation protocol in ART: should we tailor it on AMH level?
Stimulation protocol in ART: should we tailor it on AMH level?
 
caesarean myomectomy ppt.pptx
caesarean myomectomy ppt.pptxcaesarean myomectomy ppt.pptx
caesarean myomectomy ppt.pptx
 
vvf ppt.ppt
vvf ppt.pptvvf ppt.ppt
vvf ppt.ppt
 
Optimization of outcomes of .pptx
Optimization of outcomes of  .pptxOptimization of outcomes of  .pptx
Optimization of outcomes of .pptx
 
myomectomy.pptx
myomectomy.pptxmyomectomy.pptx
myomectomy.pptx
 
Diagnosis of PCOS MCMCTACONSESSION4.pptx
Diagnosis of PCOS MCMCTACONSESSION4.pptxDiagnosis of PCOS MCMCTACONSESSION4.pptx
Diagnosis of PCOS MCMCTACONSESSION4.pptx
 
COMPLICATIONS OF ASSISTED REPROUCTIVE TECHIQUES
COMPLICATIONS  OF ASSISTED REPROUCTIVE TECHIQUESCOMPLICATIONS  OF ASSISTED REPROUCTIVE TECHIQUES
COMPLICATIONS OF ASSISTED REPROUCTIVE TECHIQUES
 
PCOS.pptx
PCOS.pptxPCOS.pptx
PCOS.pptx
 
Trends of ovulation induction in PCOS
Trends of ovulation induction in PCOSTrends of ovulation induction in PCOS
Trends of ovulation induction in PCOS
 
Massive Postpartum haemorrhage
Massive Postpartum haemorrhageMassive Postpartum haemorrhage
Massive Postpartum haemorrhage
 
Pruritus in pregnancy
Pruritus in pregnancyPruritus in pregnancy
Pruritus in pregnancy
 

Recently uploaded

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
debosmitaasanyal1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 

Recently uploaded (20)

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 

Endometriosis

  • 1. Endometriosis with low AMH. How to deal with it PROF. ROKEYA BEGUM Advisor Dept. of Obs and Gynecology USTC. Director Surgiscope fertility centre Chittagong.
  • 2. Endometriosis is a…. Disease of theories and debates
  • 3. Endometriosis…. i) Defined as the presence of endometrial tissue (gland/stroma) outside the uterus. ii) Prevalence is 7-15% of reproductive age women . iii) 70 million of women are affected with endometriosis 30% of these women are infertile. iv) Estrogen dependent - Rare before menarche and after menopause. - Not in male v) Progressive disease vi) Cure by pregnancy
  • 4. Sites of Endometriosis… i) Peritoneum ii) Ovaries iii) Rectovaginal septum iv) Urinary bladder v) GI Tract
  • 5. Ovarian function… i) Hormone production ii) Maintenance of follicular development iii) Reservoir of dormant oocyte.
  • 6. Pathogenesis of ovarian endometriosis is still a matter of debate. - Superficial ovarian endometriosis. - Accumulation and activation of pelvic macrophage. Local inflammatory response, fibrosis of cortical tissue damage of dormant primordial follicle Progression of formation of endometriotic lesion in superficial ovarian cortex Provoke invagination of ovarian superficial endometriosis facilitates cyst formation. The cyst wall of endometriosis may show various degree of haemosiderin laden macrophages. Cyst wall show dense fibrosis adjacent to normal ovarian time.
  • 7. The multipotent stem cells which can form endometriotic lesion and further progression of stem cell derived lesion via tissue remodelling may be modulated by ovarian steriod hormone and local inflammation. Accumulation and trafficking of these stem cells can be stimulated by oestradiol and immune cells. Local immune cells such as in variant natural killer T (NKT) cells may be involved in pathogenesis of endometriosis.
  • 8. Ovarian steroid hormone production The direct effects of endometriosis on ovarian steroid hormone production are unclear. Altered follicular development can result in decreased hormone production lower level of oestrogen and progesterone have been noted in serum and urine . Impairment of ovulatory process causes LUFS. The causal relationship between endometriosis and LUFS are unclear and controversial.
  • 9. Oocyte quality… Oocyte maturity can be affected by inflammatory intrafollicular environment. The presence of intrafollicular oxidative stress in patients with endometriosis is an event that is directly linked to reduced oocyte quality and infertility. Oxidative stress brought by hemorrhagic chocolate fluids in endometriosis may spread to surrounding normal ovarian tissue. Assessment of quality of follicle in clinical setting is not straight forward.
  • 10. Quantity… Ovarian reserve is a term concerning the quality and quantity of ovarian follicles remains at certain time points. Ovarian reserve may refer to the quantity of remaining primordial follicles are formed in the course of ovarian development in foetal life than they maintain dormancy until they are activated in later reproductive life.
  • 11. Presence of ovarian endometriosis on ovarian reserve- 1.Adjacent ovarian tissue is morphologically altered but not functionally. 2.Compression by cyst hamper circulation and causes follicular loss. 3. Inflammatory reaction causes follicular damage. 4. Impaired vascularization. 5.High concentration of iron in cyst mediates the production of reactive oxygen species. Reactive oxygen species (ROS) along with transforming growth factor  is potent inducer of tissue fibrosis which causes follicular loss. Reactive oxygen species (ROS) is responsible for progressive ovarian tissue damage.
  • 12.
  • 14. Assessment of ovarian reserve in endometriosis has to be done by- • Serum Antimullerian hormone (AMH) • Serum Follicle stimulating hormone (FSH) • Antral follicle count (AFC) FSH and AFC have limitation- • FSH – higher intercycle variation • AFC – Not accurate with endometrioma.
  • 15. Indeed in two large Cohot studies shown women with history of endometriosis related infertility are reported to experience menopause earlier than women without endometriosis.
  • 16. Endometriosis patients suffers from… 1. Pain 2. Infertility 3. Menstrual disturbances 4. Lump in lower abdomen 5. Quality of life 6. Negative influence on sexual function 7. Inter personal relationship.
  • 17. Endometriosis is associated with infertility.. Fertility reduction is subjective choice and women could be informed but absolutely must not be terrorized leading to unnecessary stress and intervention.
  • 18. Treatment of endometriosis is individualized 1. Medical 2. Surgical 3. ART alone or combination
  • 19. * Medical treatment : - long term suppression - Reduces pain - Reduced growth of lesion - Protect ovarian function 1. GnRh agonist 2. Dienogest
  • 20. • Medical treatment suppresses general and peripheral oestrogen production result in better treatment outcome in ART cycle. • Reduction of endometriosis activity may restore endometrial receptivity as well as maintenance of ovarian reserve.
  • 21. 1. GnRh agonist - a. Reduce cyst size b. Reduction of hyper vascularization and inflammation. c. Reduction of cyst wall thickness. d. Absence of corpus luteum or follicle. e. Facilitation of surgery f. Reduction of adhesion
  • 22. Recommendation GnRh 1. Prior to IVF 2.Prior to surgery
  • 23. 2. Dienogest - Acts on multiple receptors a) Oestrogen b) Androgen c) Gluco corticoid d) Mineralo corticoid Dienogest has little impact on the metabolic parameter and having a significant impact on endometriotic lesion locally.
  • 24. Dienogest has - a. anti inflammatory b. Modulation of proinflammatory cytokine and chemokine production-which mediates via progesterone receptor. It is questionable whether dienogest can improve the clinical outcome if use before IVF or surgery.
  • 25. Surgery indicated in i) large endometrioma > 4cm ii) Extensive pelvic endometriosis iii) Prior IVF iv) Failure to hormone therapy
  • 26. Surgical treatment- Conservative surgery 1. Excision 2. Drainage 3. Ablation
  • 27. Aim of surgery Reconstruction of normal pelvic anatomy to achieve an excellent tubo-ovarian relationship and removed all visible disease . Laparoscopy is preferred over laparotomy. Ovarian tissue was present in cyst wall - 65% laparoscopy stripping - 80% laparotomy.
  • 28. All ovarian cyst are not created equal Ovarian tissue removed Well defined Capsule Dermoid 6% Serious cyst adenoma Mucinous cyst adenoma Endometrioma 54-69% (Margin of the ovarian tissue) The structural difference among different ovarian cysts yield different amounts of adjacent ovarian tissue when they are removed.
  • 29. Endometriosis is a false cyst and its cyst wall is the same as the ovarian cortex. Therefore unsafe removal of pseudo cyst may damage the ovary and interfere with future fertility.
  • 30. Laparoscopy is Gold standard. Ongoing pregnancy rate increased in infertile women with endometriosis after laparoscopy. Chance of pregnancy increased from 38-71% cases.
  • 31. Benefits of surgery… a. Decreased inflammations in pelvis. b. Decreased toxicity to gametes. c. Enhance uterine receptivity.
  • 32. High recurrence rate versus potential harmful effects on ovarian reserve make it difficult to select the most effective treatment modality for endometriosis. • Incomplete excision – recurrence high • Excessive excision – reduced reserve
  • 33. Recurrence of endometriosis: The reported recurrence rate was high => 21.5% at 2 yrs => 40-50% at 5 yrs Repeat surgery - 25%
  • 34. Reduction of ovarian reserve due to- a. Removal of healthy tissue during stripping. b.Vascular injury to electrosurgical coagulation. c. Inflammatory reaction.
  • 35. Surgical technique for cystectomy- 1. Mobilisation of ovaries 2. During mobilisation cyst usually drain on itself from the weakest point. 3. Cyst decompression by suction drainage. 4. Pitressin/vesopressin injection. 5. Cyst wall removed from normal ovarian tissue by traction and counter traction. 6. Achieve complete haemostasis by suture not by bipolar current.
  • 36. Three step techniques for ovarian endometrioma 1. Laparoscopic drainage 2. GnRh for 3 months 3. Laparoscopic Co2 laser vaporization.
  • 37. The factors which determine the amount of loss of follicles during surgery is dependent on many factors: 1. Use of electro cautery 2. Amount of inflammation 3. Number of pre existing follicle 4. Endometrioma is bilateral 5. Previous surgery 6. Expertise of surgery
  • 38. Several cross section shows endometrioma had lower ovarian reserve without surgery then healthy women. This decline is progressive in the absence of any intervention and greater in magnitude.
  • 39. Ovarian reserve in endometriosis depends on- a. Bilateral / unilateral disease. b. Size of cyst c. Severe adhesion d. Fibrosis e. Disease duration f. Women’s age g.Recurrence
  • 40. • 30% AMH reduction – unilateral • 44% AMH reduction – bilateral
  • 41. Surgery ART Age Young Old Associated factor - Male - Tube No Yes Infertility duration Short Long Ovarian reserve Satisfactory Reduced Pelvic pain Severe Mild Ovarian Endometrioma bilateral No Yes Previous surgery No Yes Adenomyomis No Yes
  • 42. Anti mullerian hormone level in women with endometriosis. A case-control study. Object – To compare the Antimullarian hormone (AMH) level in women with or without endometriosis. Design – A case control study Getting – Women’s general hospital, Lint, Austria. Result – Mean AMH level was significantly lower in the study group than in the control group (2.75 + 2.0mg/ml vs 3.46 + 2.30mg/ml P0.001) OMAR SHEBL 2009.
  • 43. Effect of ovarian endometrioma on the number of oocyte retrieved for in vitro fertilization. Objective – To evaluate the effects of ovarian endometrioma on the number of oocytes retrieved for IVF. Setting – University based tertiary medical center. Patients – 81 women with unilateral endometrioma who under want first IVF cycle. Main outcome measures – The number of antral follicles and the retrieved oocyte in the ovary that contained endometrioma were compared with those from contralaterd ovary results –Antral follicle count and number of retrieved oocytes in these women were similar to those with no endometrionma. Conclusion - The presence of ovarian endometrioma in a controlled ovarian hyper stimulation cycle for IVF treatment is not associated with reduced number of oocytes retrieved from affected ovary. Benny Almog 2010
  • 44. The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cyst . Design-Prospective clinical study on 191 patients. Objective- Bipolar, Ultrasonic scalpel and Suture. Result- Significant reduction in ovarian reserve in bipolar. Chang Zhong Li- 2009
  • 45. Endometriosis patient should be assessed individually and follow seven guidelines in order to preserve fertility.
  • 46. 1. Choosing the best surgical techniques. Still not known which one is most effective. Surgery can lead to reduction in ovarian reserve i) Excessive stripping ii) Disease itself iii) Cauterization to stop bleeding iv) Surgery induce inflammation v) Cystectomy vi) Bilateral vii) Large endometriona
  • 47. 2. Avoid unnecessary surgery - No surgery if size less than 4cm - No pain.
  • 48. 3. Measure ovarian reserve before surgery. a) Discussion of risks and benefits of surgery. b) Allowing the surgery to optimize and individual treatment modalities. c) Aggressive nature of surgery should be avoided. d) Fertility preservation should be offered.
  • 49. 4. Emergency IVF before surgery 1. Older patient > 38yrs 2. Prolong infertility 3. Low AMH
  • 50. 5. Use of GnRh analogues i) Hypoestrogenic state ii) Increase natural killer cell activity and diminished embryotoxic effects of peritoneal fluid iii) Ovarian parenchyma damage during the surgery seems to be related to cyst diameter. GnRh analogue is useful for both before surgery and IVF.
  • 51. 6. Fertility preservation/Cryopreservation i) Oocyte freezing ii) Embryo freezing iii) Ovarian cortical tissue freezing
  • 52. Oocyte freezing Survival rate 85% Fertilization rate 75% Pregnancy rate > 40% Disadvantage i) Zona hardening ii) Chromosomal aneuploidy iii) Karyotype abnormality iv) Organ malfunction v) Damage cytoskeleton
  • 53. Ovarian cortical tissue cryopreservation - Re implantation of cortical ovarian tissue into the pelvic cavity or heterotopic site. - When patient become disease free, the implanted tissue can be used in IVF and ET procedure. This method is associated with 25% follicle survival and is most successful when patient is young. Ovarian tissue cryopreservation is still experimental although pregnancies have been reported.
  • 54. 7.Role of lifestyle changes in infertile patient with endometriosis- i) Avoid late childhood obesity ii) Avoid high trans fat iii) Avoid caffeine iv) Avoid alcohol
  • 55. ART is a hope of ray for Infertile patient with low AMH. Conclusion